Market closed
Elevance Health/$ELV
14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX
About Elevance Health
Elevance Health remains one of the leading health insurers in the U.S., providing medical benefits to 47 million medical members as of December 2023. The company offers employer, individual, and government-sponsored coverage plans. Elevance differs from its peers in its unique position as the largest single provider of Blue Cross Blue Shield branded coverage, operating as the licensee for the Blue Cross Blue Shield Association in 14 states. Through acquisitions, such as the Amerigroup deal in 2012 and MMM in 2021, Elevance's reach expands beyond those states through government-sponsored programs such as Medicaid and Medicare Advantage plans, too.
Ticker
$ELV
Sector
Trading on
NYSE
Industry
Health Care Providers & Services
Headquarters
Employees
104,900
Website
Elevance Health Metrics
BasicAdvanced
$85B
Market cap
13.35
P/E ratio
$27.42
EPS
0.83
Beta
$6.52
Dividend rate
1.78%
Dividend yield
Price and volume
Market cap
$85B
Beta
0.83
52-week high
$556.17
52-week low
$362.21
Average daily volume
2M
Dividend rate
$6.52
Financial strength
Current ratio
1.495
Quick ratio
1.34
Long term debt to equity
56.264
Total debt to equity
61.87
Dividend payout ratio (TTM)
23.08%
Interest coverage (TTM)
8.84%
Management effectiveness
Return on assets (TTM)
5.37%
Return on equity (TTM)
15.50%
Valuation
Price to earnings (TTM)
13.349
Price to revenue (TTM)
0.49
Price to book
1.94
Price to tangible book (TTM)
11.34
Price to free cash flow (TTM)
97.824
Dividend yield (TTM)
1.78%
Forward dividend yield
1.78%
Growth
Revenue change (TTM)
3.20%
Earnings per share change (TTM)
9.17%
3-year revenue growth (CAGR)
9.13%
3-year earnings per share growth (CAGR)
7.24%
3-year dividend per share growth (CAGR)
13.64%
What the Analysts think about Elevance Health
Analyst Ratings
Analyst ratings (Buy, Hold, Sell) for Elevance Health stock.
Elevance Health Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
Elevance Health Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Elevance Health News
AllArticlesVideos
Robbins LLP Informs Elevance Health Inc. Stockholders that it is Investigating the Officers and Directors of ELV to Determine if They Breached Fiduciary Duties Owed to Shareholders
GlobeNewsWire·1 week ago
Elevance Health: A Quality Underpriced Stock Returning To Health
Seeking Alpha·2 weeks ago
Elevance Health Stock Falls As Anthem Faces Backlash Over Anesthesia Policy, Announces Reversal
Benzinga·2 weeks ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Elevance Health stock?
Elevance Health (ELV) has a market cap of $85B as of December 22, 2024.
What is the P/E ratio for Elevance Health stock?
The price to earnings (P/E) ratio for Elevance Health (ELV) stock is 13.35 as of December 22, 2024.
Does Elevance Health stock pay dividends?
Yes, the Elevance Health (ELV) stock pays dividends to shareholders. As of December 22, 2024, the dividend rate is $6.52 and the yield is 1.78%. Elevance Health has a payout ratio of 23.08% on a trailing twelve-month basis.
When is the next Elevance Health dividend payment date?
The next Elevance Health (ELV) dividend payment date is unconfirmed.
What is the beta indicator for Elevance Health?
Elevance Health (ELV) has a beta rating of 0.83. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.